However, we found that the above decrease amplitude of FABP4 and FABP6 was merely 11.3% and 13.8%, respectively, both FABP4 and FABP6 levels in CRC group after surgery were still higher than those in the control group. The gene discussed is FABP4; the disease is colorectal carcinoma.